EBRC In Translation

35. Reimagining Drug Discovery and Diagnostics w/ Jim Collins

EBRC SPA

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 43:48

In this episode of EBRC In Translation, Talia Jacobson and Will Grubbe interview Jim Collins of MIT, a pioneer of synthetic biology. He reflects on his path from human biomechanics and early gene circuit design to AI-driven antibiotic discovery.

Collins discusses how deep learning is enabling new antibiotics despite market challenges, what makes research translation succeed, and the growing role of computation in biology. He also recounts developing RNA diagnostics and early CRISPR-based platforms like SHERLOCK, along with efforts to expand accessible infectious disease testing. Stay up to date with PHARE BIO for antibiotic discovery.



For more information about EBRC:

Visit our website at ebrc.org. If you are interested in getting involved with the EBRC Student and Postdoc Association, fill out a membership application for graduate students and postdocs or for undergraduates and join today!

Transcription:
Episode transcripts are the unedited output from Whisper and likely contain errors.